Potential new anti-human immunodeficiency virus type 1 compounds depress virus replication in cultured human macrophages

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 6, 2004, Pages 2325-2330

  Ewart, Gary D ^a   Nasr, Najla ^c   Naif, Hassan ^c   Cox, Graeme B ^b   Cunningham, Anthony L ^c   Gage, Peter W ^b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b Biology and Environment   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

5 (N,N DIMETHYL)AMILORIDE; 5 (N,N HEXAMETHYLENE)AMILORIDE; AMILORIDE DERIVATIVE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIGEN P24; VIRUS DNA; VIRUS RNA; VPU PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL SURVIVAL; CONCENTRATION RESPONSE; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE PROLIFERATION; MACROPHAGE; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INHIBITION; VIRUS REPLICATION;

AMILORIDE; ANTI-HIV AGENTS; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; DNA, VIRAL; GENE PRODUCTS, VPU; HIV CORE PROTEIN P24; HIV-1; HUMANS; MACROPHAGES; RNA, VIRAL; VIRUS REPLICATION;

EID: 2542441626     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.6.2325-2330.2004     Document Type: Article

References (17)

1. Balliet, J. W., D. L. Kolson, G. Eiger, F. M. Kim, K. A. McGann, A. Srinivasan, and R. Collman. 1994. Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate. Virology 200:623-631.
2. Carr, J. M., H. Hocking, P. Li, and C. J. Burrell. 1999. Rapid and efficient cell to cell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes. Virology 265:319-329.
3. Du, B., A. Wolf, S. Lee, and E. Terwilliger. 1993. Changes in the host range and growth potential of an HIV-1 clone are conferred by the vpu gene. Virology 195:260-264.
4. Ewart, G. D., K. Mills, G. B. Cox, and P. W. Gage. 2002. Amiloride derivatives block ion channel activity and enhancement of virus-like particle budding caused by HIV-1 protein Vpu. Eur. Biophys. J. 31:26-35.
5. Ewart, G. D., T. Sutherland, P. W. Gage, and G. B. Cox. 1996. The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels. J. Virol. 70:7108-7115.
6. Gottlinger, H. G., T. Dorfman, E. A. Cohen, and W. A. Haseltine. 1993. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc. Natl. Acad. Sci. USA 90:7381-7385.
7. Haase, A. T., and T. W. Schaker. 1998. Potential for the transmission of HIV-1 despite highly active anti-retroviral therapy. N. Engl. J. Med. 339:1846-1848.
8. Hanauer, A., and J. L. Mandel. 1984. The glyceraldehyde 3 phosphate dehydrogenase gene family: structure of a human cDNA and of an X chromosome linked pseudogene; amazing complexity of the gene family in mouse. EMBO J. 3:2627-2633.
9. Klimkait, T., K. Strebel, M. D. Hoggan, M. A. Martin, and J. M. Orenstein. 1990. The human immunodeficiency virus type 1-specific protein Vpu is required for efficient virus maturation and release. J. Virol. 64:621-629.
10. Naif, H. M., J. Chang, M. Ho-Shon, S. Li, and A. L. Cunningham. 1996. Inhibition of human immunodeficiency virus replication in differentiating monocytes by interleukin 10 occurs in parallel with inhibition of cellular RNA expression. AIDS Res. Hum. Retrovir. 12:1237-1245.
11. Paul, M., S. Mazumder, N. Raja, and M. A. Jabbar. 1998. Mutational analysis of the human immunodeficiency virus type 1 Vpu transmembrane domain that promotes the enhanced release of virus-like particles from the plasma membrane of mammalian cells. J. Virol. 72:1270-1279.
12. Saiki, R. K., D. H. Gelfand, S. Stoffel, S. J. Scharf, R. Higuchi, G. T. Horn, K. B. Mullis, and H. A. Erlich. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491.
13. Sakai, H., K. Tokunaga, M. Kawamura, and A. Adachi. 1995. Function of human immunodeficiency virus type 1 Vpu protein in various cell types. J. Gen. Virol. 76:2717-2722.
14. Schubert, U., S. Bour, A. V. Ferrermontiel, M. Montal, F. Maldarelli, and K. Strebel. 1996. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J. Virol. 70:809-819.
15. Schubert, U., K. A. Clouse, and K. Strebel. 1995. Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes. J. Virol. 69:7699-7711.
16. Schubert, U., A. V. Ferrermontiel, M. Oblattmontal, P. Henklein, K. Strebel, and M. Montal. 1996. Identification of an ion channel activity of the vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells. FEBS Lett. 398:12-18.
17. Strebel, K., T. Klimkait, and M. A. Martin. 1988. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science 241:1221-1223.